Buckley Kohlhauff
Director Técnico/Científico/I+D en NURIX THERAPEUTICS, INC. .
Cargos activos de Buckley Kohlhauff
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NURIX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/09/2021 | - |
Historial de carrera de Buckley Kohlhauff
Antiguos cargos conocidos de Buckley Kohlhauff.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - | - |
FIVE PRIME THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
Formación de Buckley Kohlhauff.
Carnegie Mellon University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NURIX THERAPEUTICS, INC. | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
- Bolsa de valores
- Insiders
- Buckley Kohlhauff
- Experiencia